Voyager Therapeutics (VYGR) Tax Provisions (2016 - 2026)
Voyager Therapeutics (VYGR) posted Tax Provisions of $14000.0 for Q1 2026, up 55.56% sequentially from $9000.0 in Q4 2025, and down 62.16% YoY from $37000.0 in Q1 2025.
Voyager Therapeutics (VYGR) Tax Provisions (2016 - 2026) Analysis & Trends
Voyager Therapeutics has reported Tax Provisions for 7 years, with the latest figure at $14000.0 in Q1 2026.
- Quarterly Tax Provisions fell 62.16% year-over-year to $14000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $121000.0 (down 38.89% YoY) and the FY2025 annual result came in at $144000.0, down 17.71% from the prior year.
- Tax Provisions grew to $14000.0 in Q1 2026 per VYGR's latest filing, from $9000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $704000.0 in Q1 2023 and troughed at -$472000.0 in Q4 2023.
- A 4-year average of $34384.6 and a median of $24000.0 in 2024 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions sank 98.01% in 2024, then jumped 164.29% in 2025.
- Over 4 years, Tax Provisions stood at -$472000.0 in 2023, then soared by 119.92% to $94000.0 in 2024, then plunged by 90.43% to $9000.0 in 2025, then surged by 55.56% to $14000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $14000.0, $9000.0, and $83000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Mar 31, 2026 | 14,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 83,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | -472,000.00 |
| Sep 30, 2023 | -177,000.00 |
| Jun 30, 2023 | 59,000.00 |
| Mar 31, 2023 | 704,000.00 |
| Mar 31, 2018 | -180,000.00 |
| Jun 30, 2017 | 195,000.00 |
| Mar 31, 2017 | -226,000.00 |
| Dec 31, 2016 | 355,000.00 |
| Sep 30, 2016 | -303,000.00 |